NCT05714553 2025-07-18
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Phase 1/2 Terminated
NuCana plc
M.D. Anderson Cancer Center
Amphia Hospital
University of California, San Francisco
Stanford University
Ziekenhuis Oost-Limburg